Roivant Sciences: director Melissa B Epperly sold 17,750 shares

What happened

• Melissa B Epperly, director, exercised options to acquire 17,750 common shares at $4.46 per share for $79,165 and, on the same date, sold a total of 17,750 common shares in open-market transactions for $640,861. The filing also shows a derivative disposition of 17,750 shares at $0.00.

Key details

• Transaction date: Oct 1, 2026.
• Exercise: 17,750 shares at $4.46, total $79,165.
• Sales: 16,850 shares at a weighted average price of $36.08 for $607,948 (sales ranged $35.46 to $36.45); 900 shares at a weighted average price of $36.57 for $32,913 (sales ranged $36.48 to $36.72). Total sale proceeds $640,861.
• Derivative entry: 17,750 shares disposed at $0.00 (listed as a derivative transaction).
• Footnotes: the sales were effected under a Rule 10b5-1 trading plan adopted Mar 30, 2026; reported sale prices are weighted averages and the filer will provide breakdowns on request; the option award reflected is fully vested.
• Filing: document filed Oct 5, 2026; filing is not marked late.

Why it may matter

• The filing shows an exercise of options and concurrent open-market sales of the same number of shares on the same date, consistent with an immediate sale of exercised shares (cashless-style transaction).
• This filing does not show why the insider traded or why the company acted.